Rectal Carcinoma — Trials

Rectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

332 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 94
Recruiting: 52
Ph III recruiting: 6
Growth YoY: +8.7%
Industry share: 2%
Top sponsor: City of Hope Medical Center
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 51–52 of 52 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00964457	Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients	unknown	Phase 2	60	Copenhagen University Hospital at HerlevOTHER	1	Aug 25, 2009	clinicaltrials
NCT00557713	XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma	unknown	Phase 2	44	Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials